1–4 of 4 results for Leo A. Kim
From Bench to Bedside: Investigating the Use of Netarsudil as a Novel Therapeutic Approach for PVR
Leo A. Kim, MD, PhD
Updates from the Field
2025
Rho-kinase Inhibition on an In Vitro Patient-Derived Model of Proliferative Vitreoretinopathy
Annual Meeting Talks
2021
Single Cell Genome-Wide Expression Profiling of Patient-Derived Membranes in Proliferative Vitreoretinopathy
2020
Regulation of Epithelial-Mesenchymal Transition via RUNX1 in Proliferative Vitreoretinopathy
On Demand Cases, Courses, and Papers
2019